Page last updated: 2024-08-25

zoledronic acid and Osseous Paget's Disease

zoledronic acid has been researched along with Osseous Paget's Disease in 82 studies

Research

Studies (82)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (6.10)	18.2507
2000's	34 (41.46)	29.6817
2010's	33 (40.24)	24.3611
2020's	10 (12.20)	2.80

Authors

Authors	Studies
Gao, P; Jiang, Y; Li, M; Wang, O; Xia, W; Xing, X; Yan, S; Zhang, Q; Zhang, Y	1
Collaceli, MD; Jerkovich, F; Rey, P; Sarli, M; Spivacow, R; Zanchetta, MB	1
Abate, V; Cavati, G; Falchetti, A; Gennari, L; Merlotti, D; Mingiano, C; Nuti, R; Rendina, D	1
Blanch, J; Boers, M; Brandi, ML; Cetnarskyj, R; Chandra, R; Charnock, K; Cronin, O; Crowley, RK; Del Pino-Montes, J; Devogelaer, JP; Di Stefano, M; Duncan, EL; Durnez, A; Forsyth, L; Fraser, WD; Gennari, L; Gilchrist, NL; Goodman, K; Guañabens, N; Hampson, G; Ho, S; Horne, A; Isaia, G; Keerie, C; Kotowicz, MA; Lewis, SC; Major, G; McKenna, MJ; Murray, GD; Nicholson, GC; Nuti, R; Porteous, M; Ralston, SH; Ranganath, LR; Russell, RGG; Seibel, MJ; Selby, PL; Tobias, JH; Walker, A; Walsh, JP; Wilkinson, D; Young-Min, S	1
Reid, IR	3
Arboiro Pinel, R; Blanes Jacquart, D; de la Piedra Gordo, C; Díaz Curiel, M; Moro Álvarez, MJ; Rodríguez-Olleros Rodríguez, C	1
Brandi, ML; Cetnarskyj, R; Chandra, R; Cronin, O; Crowley, RK; Del Pino-Montes, J; Devogelaer, JP; Di Stefano, M; Duncan, EL; Durnez, A; Forsyth, L; Fraser, WD; Gennari, L; Gilchrist, NL; Goodman, K; Guanabens, N; Hampson, G; Ho, S; Horne, A; Isaia, GC; Keerie, C; Kotowicz, MA; Lewis, SC; Major, G; McKenna, MJ; Nicholson, GC; Nuti, R; Porteous, M; Ralston, SH; Ranganath, LR; Rubio, JB; Seibel, MJ; Selby, PL; Subedi, D; Tang, J; Tobias, JH; Walker, A; Walsh, JP; Young-Min, SA	1
Black, DM; Cummings, SR; Eriksen, EF; Green, JR; Hosking, DJ; Lyles, KW; Reid, DM; Reid, IR; Russell, RGG; Trechsel, U	1
Ralston, SH	1
Abate, V; Buonaiuto, A; De Filippo, G; Di Minno, MND; Evangelista, M; Gennari, L; Gentile, M; Giaquinto, A; Iannuzzo, G; Merlotti, D; Picchioni, T; Rendina, D; Strazzullo, P	1
Barale, M; Bioletto, F; Ghigo, E; Maiorino, F; Mazzetti, R; Procopio, M; Sigrist, S	1
Maslowski, K; Reid, IR	1
Burbidge, AM; Dunlop, A; Haider, AS	1
Amling, M; Butscheidt, S; Rolvien, T; Zustin, J	1
Alikasifoglu, A; Buyukyilmaz, G; Gonc, EN; Kandemir, N; Ozon, A; Simsek, OP	1
Calero-Paniagua, I; Fuentes-Calvo, I; García-Ortiz, L; González-Sarmiento, R; Martínez-Salgado, C; Moledo-Pouso, C; Pino-Montes, JD; Usategui-Martín, R	1
Charlesworth, G; Daroszewska, A; Prior, A; Ralston, SH; Rose, K; Rose, L; Sarsam, N; van 't Hof, RJ	1
Cooper, C; Corral-Gudino, L; Francis, RM; Fraser, WD; Gennari, L; Guañabens, N; Javaid, MK; Layfield, R; O'Neill, TW; Ralston, SH; Russell, RGG; Simpson, K; Stone, MD; Tuck, SP; Wilkinson, D; Wills, R; Zillikens, MC	1
Evangelatos, G; Fragoulis, GE; Iliopoulos, A	1
Erra, A; Grados, D; Holgado, S; Martínez-Morillo, M	1
Abraham, I; Boonen, S; Daci, E; Denhaerynck, K; Devogelaer, JP; Geusens, P; Gielen, E; Hermans, C; Macdonald, K; Vancayzeele, S	1
Correa, PH; Ferraz-de-Souza, B	1
Eccleston, DS; Ellims, AH; Watts, MR	1
Baykan, EK; Cetinkalp, S; Erdogan, M; Ozgen, AG; Saygılı, LF; Yilmaz, C	1
Gonçalves, MJ; Romão, VC	1
Árvai, K; Balla, B; Donáth, J; Juhász, P; Kósa, JP; Lakatos, P; Poór, G; Speer, G	1
Tucci, JR	1
Mohamed, M	1
Hephzibah, J; Kapoor, N; Paul, TV; Sathyakumar, S	1
Feichtinger, X; Haschka, J; Kocijan, R; Muschitz, C	1
Cundy, T; Grey, A; Maslowski, K; Reid, IR	1
Kannan, S; Mahadevan, S; Sathya, A; Sriram, U	1
Arsos, G; Avramidis, A; Efstathiadou, Z; Grollios, G; Karakatsanis, K; Kita, M; Moralidis, E; Polyzos, SA	1
Cunnane, G; Delaney, H; Doran, MF; Sheane, BJ	1
Oliver, RJ; Seehra, J; Sloan, P	1
Anastasilakis, AD; Arsos, G; Avramidis, A; Efstathiadou, Z; Gerou, S; Kita, M; Litsas, I; Moralidis, E; Papatheodorou, A; Pavlidou, V; Polyzos, SA; Terpos, E	1
De Paola, V; Gennari, L; Martini, G; Merlotti, D; Mossetti, G; Nuti, R; Rendina, D	1
Albert, JD; Chalès, G; Duval, H; El Mansouri, L; Guggenbuhl, P; Hajjaj-Hassouni, N; Meadeb, JM	1
Li-Yu, J; Maderazo, E	1
Civantos Modino, S; Díaz Guardiola, P; Guijarro de Armas, MG; Montaño Martínez, JM; Pavón de Paz, I; Zubieta Tabernero, J	1
Anastasilakis, AD; Arsos, G; Kita, M; Kountouras, J; Litsas, I; Moralidis, E; Polyzos, SA; Terpos, E	1
Anastasilakis, AD; Arsos, G; Efstathiadou, Z; Kita, M; Litsas, I; Moralidis, E; Papatheodorou, A; Polyzos, SA; Terpos, E	1
Andrikoula, M; Gkouva, L; Kontogeorgakos, V; Papachristou, DJ; Tsatsoulis, A	1
Díaz, CA; Fidalgo, S; Lutfi, RJ; Saban, M	1
Polyzos, SA	1
de Magalhães Souza Fialho, SC; Heiden, GI; Morato, EF; Neves, FS; Pereira, IA; Toscano, MA; Werner de Castro, GR; Zimmermann, AF	1
Brown, JP; Bucci-Rechtweg, C; Cafoncelli, S; del Pino-Montes, J; Fraser, WD; Hosking, DJ; Lyles, K; Miller, PD; Reid, IR; Su, G; Walsh, JP	1
Britton, C; Walsh, J	1
Anagnostis, P; Anastasilakis, AD; Arsos, G; Kita, M; Moralidis, E; Papatheodorou, A; Polyzos, SA; Terpos, E	1
Correa, PH; Ferraz-de-Souza, B; Martin, RM	1
Boissier, S; Cabon, F; Clézardin, P; Colombel, M; Filleur, S; Fournier, P; Guglielmi, J	1
Chung, G; Keen, RW	1
Morton, A	1
Deftos, LJ	1
Brown, JP; Fraser, W; Hosking, D; Luchi, M; Lyles, K; Mesenbrink, P; Miller, P; Pak, J; Reid, IR; Richardson, P; Saidi, Y; Su, G; Zelenakas, K	1
Liel, Y	1
De Filippo, G; Mossetti, G; Rendina, D	1
Füessl, HS	1
Hosking, D	1
Maricic, M	2
Krane, SM	1
Brown, JP; Curiel, MD; Devogelaer, JP; Eriksen, EF; Fashola, T; Fraser, WD; Hooper, M; Hosking, D; Lyles, K; Miller, P; Pak, J; Reid, IR; Saidi, Y; Su, G; Zelenakas, K	1
Almirall Bernabé, M; Carbonell Abelló, J; Conesa Mateos, A; Rotés Sala, D	1
Bandeira, F; Colares, V; Griz, L	1
Keating, GM; Scott, LJ	1
Avanzati, A; De Paola, V; Gennari, L; Martini, G; Merlotti, D; Nuti, R; Valleggi, F	1
Pane, A	1
Devogelaer, JP; Manicourt, DH	1
Abelson, A	1
Birbilis, T; Gymnopoulou, E; Oikonomou, A; Prassopoulos, P	1
Gueiros, LA; Leão, JC; Lopes, MA	1
Bergmann, P; Body, JJ; Boonen, S; Boutsen, Y; Devogelaer, JP; Goemaere, S; Kaufman, JM; Reginster, JY; Rozenberg, S	1
Delmas, PD	1
Siris, E	1
Arden-Cordone, M; Knieriem, A; Lyles, KW; Newton, RA; Schaffer, V; Siris, ES; Zelenakas, K	1
Delmas, PD; Garnero, P; Gineyts, E; Schaffer, AV; Seaman, J	1
Birbara, CA; Buckler, H; Davie, M; Fogelman, I; Fraser, W; Hosking, D; Lyles, K; Maricic, MJ; Moses, AM; Richardson, P; Ryan, W; Seaman, J; Selby, P; Singer, F; Siris, E; Zelenakas, K	1
Christgau, S; Delmas, PD; Garnero, P	1

Reviews

14 review(s) available for zoledronic acid and Osseous Paget's Disease

Article	Year
Drug treatment strategies for paget's disease: relieving pain and preventing progression. Expert opinion on pharmacotherapy, 2023, Volume: 24, Issue:6 Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Osteitis Deformans; Pain; Zoledronic Acid	2023
Recent advances in understanding and managing Paget's disease. F1000Research, 2019, Volume: 8 Topics: Clinical Trials as Topic; Diphosphonates; Disease Management; Disease Progression; Humans; Osteitis Deformans; Quality of Life; Remission Induction; Zoledronic Acid	2019
Management of Paget's disease of bone. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2020, Volume: 31, Issue:5 Topics: Bone and Bones; Diphosphonates; Humans; Osteitis Deformans; Quality of Life; Zoledronic Acid	2020
Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2019, Volume: 34, Issue:4 Topics: Adult; Alkaline Phosphatase; Biomarkers; Humans; Osteitis Deformans; Practice Guidelines as Topic; Zoledronic Acid	2019
Diagnosis and treatment of Paget's disease of bone: a mini-review. Arquivos brasileiros de endocrinologia e metabologia, 2013, Volume: 57, Issue:8 Topics: Alkaline Phosphatase; Asymptomatic Diseases; Bone Density Conservation Agents; Calcium; Diagnosis, Differential; Diphosphonates; Humans; Imidazoles; Osteitis Deformans; Radiography; Vitamin D; Zoledronic Acid	2013
Diagnosis and treatment of Paget's disease of bone : A clinical practice guideline. Wiener medizinische Wochenschrift (1946), 2017, Volume: 167, Issue:1-2 Topics: Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Remodeling; Diagnostic Imaging; Diphosphonates; Follow-Up Studies; Humans; Imidazoles; Osteitis Deformans; Practice Guidelines as Topic; Zoledronic Acid	2017
The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone. Mini reviews in medicinal chemistry, 2009, Volume: 9, Issue:9 Topics: Animals; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Injections, Intravenous; Osteitis Deformans; Pamidronate; Zoledronic Acid	2009
Pharmacological therapy of Paget's and other metabolic bone diseases. Bone, 2006, Volume: 38, Issue:2 Suppl 2 Topics: Bone Density Conservation Agents; Bone Resorption; Clinical Trials as Topic; Diphosphonates; Etidronic Acid; Humans; Imidazoles; Osteitis Deformans; Osteogenesis; Risedronic Acid; Zoledronic Acid	2006
The use of zoledronic acid for Paget's disease of bone. Current osteoporosis reports, 2006, Volume: 4, Issue:1 Topics: Bone Density; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Osteitis Deformans; Treatment Outcome; Zoledronic Acid	2006
[Treatment of Paget's disease of bone: importance of the zoledronic acid]. Arquivos brasileiros de endocrinologia e metabologia, 2006, Volume: 50, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Resorption; Calcitonin; Diphosphonates; Female; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Hypercalcemia; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Pamidronate; Remission Induction; Treatment Outcome; Zoledronic Acid	2006
Zoledronic acid: a review of its use in the treatment of Paget's disease of bone. Drugs, 2007, Volume: 67, Issue:5 Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Infusions, Intravenous; Osteitis Deformans; Treatment Outcome; Zoledronic Acid	2007
Zoledronic acid for treatment of Paget's disease of bone. Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:16 Topics: Animals; Bone Density Conservation Agents; Clinical Trials as Topic; Diphosphonates; Humans; Imidazoles; Osteitis Deformans; Zoledronic Acid	2007
Zoledronic acid for Paget's disease of bone. Drugs of today (Barcelona, Spain : 1998), 2007, Volume: 43, Issue:12 Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Injections, Intravenous; Osteitis Deformans; Quality of Life; Zoledronic Acid	2007
A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg. Current medical research and opinion, 2008, Volume: 24, Issue:3 Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Disease Progression; Etidronic Acid; Humans; Imidazoles; Middle Aged; Osteitis Deformans; Pamidronate; Risedronic Acid; Risk Factors; Treatment Outcome; Zoledronic Acid	2008

Trials

14 trial(s) available for zoledronic acid and Osseous Paget's Disease

Article	Year
Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent BMJ open, 2019, 09-04, Volume: 9, Issue:9 Topics: Adult; Anxiety; Bone Density Conservation Agents; Depression; Genetic Testing; Humans; Musculoskeletal Pain; Mutation; Osteitis Deformans; Quality of Life; Radionuclide Imaging; Randomized Controlled Trials as Topic; Sequestosome-1 Protein; Zoledronic Acid	2019
Remission over 3 years in patients with Paget disease of bone treated with a single intravenous infusion of 5 mg zoledronic acid. Calcified tissue international, 2014, Volume: 94, Issue:3 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Osteoporosis; Treatment Outcome; Zoledronic Acid	2014
ZOLEDRONIC ACID THERAPY OF PATIENTS WITH PAGET DISEASE OF BONE RESISTANT TO OR WITH UNSUSTAINED REMISSION FOLLOWING PRIOR BISPHOSPHONATE THERAPY. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2015, Volume: 21, Issue:10 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Drug Resistance; Female; Humans; Imidazoles; Male; Middle Aged; Osteitis Deformans; Remission Induction; Treatment Failure; Zoledronic Acid	2015
Durability of Response to Zoledronate Treatment and Competing Mortality in Paget's Disease of Bone. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2017, Volume: 32, Issue:4 Topics: Administration, Intravenous; Aged; Aged, 80 and over; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Osteitis Deformans; Peptide Fragments; Procollagen; Zoledronic Acid	2017
Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone. Journal of bone and mineral metabolism, 2008, Volume: 26, Issue:6 Topics: Adult; Aged; Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Osteitis Deformans; Prospective Studies; Radionuclide Imaging; Zoledronic Acid	2008
The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2009, Volume: 41, Issue:11 Topics: Aged; Case-Control Studies; Cohort Studies; Diphosphonates; Female; Humans; Imidazoles; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Osteitis Deformans; Osteoprotegerin; Prospective Studies; RANK Ligand; Zoledronic Acid	2009
Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. The New England journal of medicine, 2005, Sep-01, Volume: 353, Issue:9 Topics: Administration, Oral; Aged; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Remodeling; Diphosphonates; Double-Blind Method; Etidronic Acid; Female; Humans; Imidazoles; Infusions, Intravenous; Male; Osteitis Deformans; Quality of Life; Risedronic Acid; Zoledronic Acid	2005
Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease? Nature clinical practice. Rheumatology, 2006, Volume: 2, Issue:4 Topics: Administration, Oral; Adult; Bone Density Conservation Agents; Diphosphonates; Dose-Response Relationship, Drug; Double-Blind Method; Etidronic Acid; Follow-Up Studies; Humans; Imidazoles; Infusions, Intravenous; Osteitis Deformans; Risedronic Acid; Treatment Outcome; Zoledronic Acid	2006
Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2007, Volume: 22, Issue:1 Topics: Administration, Oral; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Follow-Up Studies; Humans; Imidazoles; Infusions, Intravenous; Osteitis Deformans; Risedronic Acid; Zoledronic Acid	2007
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2007, Volume: 22, Issue:10 Topics: Aged; Diphosphonates; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Imidazoles; Injections, Intravenous; Male; Osteitis Deformans; Pain; Pamidronate; Quality of Life; Time Factors; Zoledronic Acid	2007
Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone. Calcified tissue international, 1997, Volume: 60, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers; Bone Resorption; Calcium; Creatinine; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Hydroxyproline; Imidazoles; Infusions, Intravenous; Male; Osteitis Deformans; Zoledronic Acid	1997
Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease. Arthritis and rheumatism, 1998, Volume: 41, Issue:2 Topics: Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Collagen; Collagen Type I; Diphosphonates; Female; Humans; Imidazoles; Isomerism; Male; Middle Aged; Osteitis Deformans; Peptides; Urine; Zoledronic Acid	1998
Single infusion of zoledronate in Paget's disease of bone: a placebo-controlled, dose-ranging study. Bone, 1999, Volume: 24, Issue:5 Suppl Topics: Aged; Alkaline Phosphatase; Biomarkers; Bone Resorption; Creatinine; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Hydroxyproline; Imidazoles; Infusions, Intravenous; Male; Osteitis Deformans; Zoledronic Acid	1999
The bisphosphonate zoledronate decreases type II collagen breakdown in patients with Paget's disease of bone. Bone, 2001, Volume: 28, Issue:5 Topics: Aged; Biomarkers; Bone and Bones; Cartilage; Collagen; Collagen Type I; Diphosphonates; Female; Humans; Imidazoles; Male; Osteitis Deformans; Peptides; Zoledronic Acid	2001

Other Studies

54 other study(ies) available for zoledronic acid and Osseous Paget's Disease

Article	Year
Clinical, Biochemical, Radiological, and Genetic Analyses of a Patient with VCP Gene Variant-Induced Paget's Disease of Bone. Calcified tissue international, 2022, Volume: 110, Issue:4 Topics: Female; Fractures, Compression; Frontotemporal Dementia; Humans; Muscular Diseases; Mutation; Osteitis Deformans; Pain; Profilins; Spinal Fractures; Valosin Containing Protein; Zoledronic Acid	2022
Clinical features, diagnostic evaluation and responses to treatment in Paget's disease of bone in a center specialized in bone metabolism. Medicina, 2022, Volume: 82, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Argentina; Diphosphonates; Female; Humans; Male; Middle Aged; Osteitis Deformans; Zoledronic Acid	2022
Long term effects on biochemical bone markers of a single infusion of zoledronic acid in Paget disease of bone. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2020, Volume: 25, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers; Bone Density Conservation Agents; Collagen Type I; Female; Humans; Male; Middle Aged; Osteitis Deformans; Peptide Fragments; Peptides; Procollagen; Prospective Studies; Zoledronic Acid	2020
Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study Cohort. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2020, Volume: 35, Issue:7 Topics: Adaptor Proteins, Signal Transducing; Female; Humans; Male; Middle Aged; Mutation; Osteitis Deformans; Sequestosome-1 Protein; Zoledronic Acid	2020
Zoledronate. Bone, 2020, Volume: 137 Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Osteitis Deformans; Osteoporosis; Zoledronic Acid	2020
Bisphosphonates in the management of Paget's disease. Bone, 2020, Volume: 138 Topics: Alendronate; Diphosphonates; Humans; Osteitis Deformans; Risedronic Acid; Zoledronic Acid	2020
Effects of Bisphosphonate Treatment on Circulating Lipid and Glucose Levels in Patients with Metabolic Bone Disorders. Calcified tissue international, 2021, Volume: 108, Issue:6 Topics: Bone Density Conservation Agents; Diphosphonates; Glucose; Humans; Lipids; Osteitis Deformans; Retrospective Studies; Zoledronic Acid	2021
Long-Term Efficacy of Intensive Zoledronate Therapy and Predictors of Retreatment in Paget's Disease of Bone. Calcified tissue international, 2021, Volume: 109, Issue:4 Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Male; Middle Aged; Osteitis Deformans; Retreatment; Retrospective Studies; Zoledronic Acid	2021
Long-Term Bone Scintigraphy Results After Intravenous Zoledronate in Paget's Disease of Bone. Calcified tissue international, 2017, Volume: 101, Issue:1 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Osteitis Deformans; Radionuclide Imaging; Time; Zoledronic Acid	2017
Bilateral Ocular Pain and Hyperemia in a Patient With Paget Disease of the Bone. JAMA ophthalmology, 2017, 06-01, Volume: 135, Issue:6 Topics: Acute Disease; Bone Density Conservation Agents; Conjunctival Diseases; Diphosphonates; Eye Hemorrhage; Eye Pain; Humans; Hyperemia; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Uveitis, Anterior; Zoledronic Acid	2017
Skeletal dissemination in Paget's disease of the spine. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2018, Volume: 27, Issue:Suppl 3 Topics: Alkaline Phosphatase; Diphosphonates; Disease Progression; Humans; Iatrogenic Disease; Male; Middle Aged; Osteitis Deformans; Postoperative Complications; Spine; Tomography, X-Ray Computed; Zoledronic Acid	2018
Acquired resistance to pamidronate treated effectively with zoledronate in juvenile Paget's disease. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2018, Volume: 29, Issue:6 Topics: Bone Density Conservation Agents; Drug Resistance; Drug Substitution; Gene Deletion; Humans; Infant; Male; Osteitis Deformans; Osteoprotegerin; Pamidronate; Radiography; Zoledronic Acid	2018
Influence Of Angiogenic Mediators And Bone Remodelling In Paget´s Disease Of Bone. International journal of medical sciences, 2018, Volume: 15, Issue:11 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Remodeling; Cohort Studies; Cytokines; Female; Humans; Male; Neovascularization, Pathologic; Osteitis Deformans; Osteoprotegerin; RANK Ligand; Spain; Zoledronic Acid	2018
Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62 Disease models & mechanisms, 2018, 08-23, Volume: 11, Issue:9 Topics: Aging; Animals; Bone and Bones; Bone Resorption; Calcification, Physiologic; Disease Models, Animal; Mice, Inbred C57BL; Mice, Mutant Strains; Mutation; Organ Size; Osteitis Deformans; Osteoclasts; Phenotype; Sequestosome-1 Protein; Zoledronic Acid	2018
Twenty-year scintigraphic follow-up of calcitonin versus zoledronic acid in Paget's disease of bones. Rheumatology (Oxford, England), 2019, 10-01, Volume: 58, Issue:10 Topics: Bone Density Conservation Agents; Calcitonin; Drug Substitution; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Middle Aged; Osteitis Deformans; Radionuclide Imaging; Treatment Outcome; Zoledronic Acid	2019
[Intravenous bisphosphonates for bone Paget's disease: higher risk of adverse events]. Medicina clinica, 2014, May-20, Volume: 142, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Male; Middle Aged; Osteitis Deformans; Retrospective Studies; Treatment Outcome; Zoledronic Acid	2014
Acute myopericarditis following intravenous zoledronic acid for the treatment of Paget's disease. The Medical journal of Australia, 2014, Feb-17, Volume: 200, Issue:3 Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Myocarditis; Osteitis Deformans; Pericarditis; Zoledronic Acid	2014
Efficacy of zoledronic acid treatment in Paget disease of bone. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2014, Volume: 25, Issue:9 Topics: Aged; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone Density Conservation Agents; Diphosphonates; Drug Evaluation; Female; Humans; Imidazoles; Male; Middle Aged; Osteitis Deformans; Osteocalcin; Remission Induction; Retrospective Studies; Treatment Outcome; Zoledronic Acid	2014
Images in clinical medicine. Saber tibia in Paget's disease of bone. The New England journal of medicine, 2014, Dec-18, Volume: 371, Issue:25 Topics: Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Humans; Imidazoles; Male; Middle Aged; Osteitis Deformans; Radiography; Tibia; Zoledronic Acid	2014
Polymorphisms of CSF1 and TM7SF4 genes in a case of mild juvenile Paget's disease found using next-generation sequencing. Croatian medical journal, 2015, Volume: 56, Issue:2 Topics: Adaptor Proteins, Signal Transducing; Adult; Bone Density Conservation Agents; Diphosphonates; DNA Mutational Analysis; Female; High-Throughput Nucleotide Sequencing; Humans; Imidazoles; Macrophage Colony-Stimulating Factor; Membrane Proteins; Mutation, Missense; Osteitis Deformans; Polymorphism, Genetic; Radiography; Zoledronic Acid	2015
Two diagnoses from bone marrow biopsy: multiple myeloma and Paget's disease of bone. BMJ case reports, 2016, Feb-24, Volume: 2016 Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Bortezomib; Dexamethasone; Diphosphonates; Humans; Imidazoles; Male; Middle Aged; Multiple Myeloma; Osteitis Deformans; Treatment Outcome; Zoledronic Acid	2016
Unusual presentation of Paget's disease of bone. BMJ case reports, 2016, Mar-04, Volume: 2016 Topics: Alkaline Phosphatase; Blepharoptosis; Diphosphonates; Humans; Imidazoles; Male; Middle Aged; Osteitis Deformans; Tomography, Emission-Computed; Treatment Outcome; Zoledronic Acid	2016
A tale of three diseases of the bone. Singapore medical journal, 2008, Volume: 49, Issue:10 Topics: Absorptiometry, Photon; Aged; Bone and Bones; Bone Density; Calcium Carbonate; Cholecalciferol; Diphosphonates; Female; Humans; Hypocalcemia; Imidazoles; Lumbar Vertebrae; Osteitis Deformans; Osteomalacia; Vitamin D Deficiency; Zoledronic Acid	2008
A classical presentation of Paget disease of bone. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2008, Volume: 14, Issue:6 Topics: Aged; Alkaline Phosphatase; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Femur; Humans; Imidazoles; Male; Osteitis Deformans; Pelvis; Radiography; Zoledronic Acid	2008
Paget's disease of bone and osteonecrosis. Dental update, 2009, Volume: 36, Issue:3 Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Dry Socket; Female; Humans; Hypercementosis; Imidazoles; Injections, Intravenous; Maxillary Diseases; Osteitis Deformans; Osteonecrosis; Pamidronate; Skull; Tooth Extraction; Tooth Socket; Zoledronic Acid	2009
Bifocal sarcomatous transformation of Paget's disease: a case report. Joint bone spine, 2009, Volume: 76, Issue:5 Topics: Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Calcium; Cell Transformation, Neoplastic; Diphosphonates; Humans; Imidazoles; Male; Osteitis Deformans; Osteosarcoma; Pleural Effusion; Tomography, X-Ray Computed; Vitamin D; Zoledronic Acid	2009
A rare case of Paget's disease of the bone in the Philippines. International journal of rheumatic diseases, 2009, Volume: 12, Issue:4 Topics: Bone and Bones; Bone Density Conservation Agents; Calcium Compounds; Dietary Supplements; Diphosphonates; Exercise Therapy; Female; Humans; Imidazoles; Osteitis Deformans; Philippines; Radiography, Thoracic; Range of Motion, Articular; Treatment Outcome; Vitamin D; Zoledronic Acid	2009
[Primary hyperparathyroidism in a patient with Paget's bone disease]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57, Issue:4 Topics: Adenoma; Aged; Alkaline Phosphatase; Bone Density; Bone Diseases, Metabolic; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyroidism; Imidazoles; Osteitis Deformans; Osteoporosis; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Radionuclide Imaging; Zoledronic Acid	2010
Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of bone. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2011, Volume: 22, Issue:1 Topics: Bone Density Conservation Agents; Chemical and Drug Induced Liver Injury; Diphosphonates; Fatty Liver; Female; Follow-Up Studies; Humans; Imidazoles; Middle Aged; Non-alcoholic Fatty Liver Disease; Osteitis Deformans; Radionuclide Imaging; Zoledronic Acid	2011
Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease. Journal of bone and mineral metabolism, 2010, Volume: 28, Issue:6 Topics: Adult; Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Drug Monitoring; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Imidazoles; Osteitis Deformans; Radiography; Zoledronic Acid	2010
Active Paget's disease of bone with normal biomarkers of bone metabolism: a case report and review of the literature. Clinical rheumatology, 2011, Volume: 30, Issue:1 Topics: Aged; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Osteitis Deformans; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Technetium; Zoledronic Acid	2011
[Effect of a single dose of zoledronic acid in a case of Paget bone disease]. Medicina, 2010, Volume: 70, Issue:5 Topics: Aged, 80 and over; Alkaline Phosphatase; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Male; Osteitis Deformans; Radionuclide Imaging; Remission Induction; Treatment Outcome; Zoledronic Acid	2010
Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget's disease of bone. Clinical rheumatology, 2011, Volume: 30, Issue:1 Topics: Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Diphosphonates; Female; Humans; Imidazoles; Osteitis Deformans; Osteoporosis; Postmenopause; Remission Induction; Treatment Outcome; Zoledronic Acid	2011
Paget's disease of bone: analysis of 134 cases from an island in Southern Brazil: another cluster of Paget's disease of bone in South America. Rheumatology international, 2012, Volume: 32, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Density Conservation Agents; Brazil; Cluster Analysis; Comorbidity; Deafness; Diphosphonates; Female; Fibrous Dysplasia, Polyostotic; Fractures, Bone; Humans; Hydrocephalus; Imidazoles; Male; Middle Aged; Osteitis Deformans; Polyradiculopathy; Retrospective Studies; Treatment Outcome; Zoledronic Acid	2012
A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2011, Volume: 26, Issue:9 Topics: Aged; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Humans; Imidazoles; Infusions, Intravenous; Kaplan-Meier Estimate; Osteitis Deformans; Quality of Life; Radionuclide Imaging; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Treatment Outcome; Zoledronic Acid	2011
Paget disease of bone - an update. Australian family physician, 2012, Volume: 41, Issue:3 Topics: Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Humans; Imidazoles; Middle Aged; Osteitis Deformans; Risedronic Acid; Zoledronic Acid	2012
Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid. Endokrynologia Polska, 2012, Volume: 63, Issue:4 Topics: Aged; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Disease Progression; Fatal Outcome; Female; Health Status; Heart Failure; Humans; Imidazoles; Osteitis Deformans; Treatment Outcome; Zoledronic Acid	2012
Symptomatic intracranial hypertension and prolonged hypocalcemia following treatment of Paget's disease of the skull with zoledronic acid. Journal of bone and mineral metabolism, 2013, Volume: 31, Issue:3 Topics: Diphosphonates; Female; Humans; Hypocalcemia; Imidazoles; Intracranial Hypertension; Middle Aged; Osteitis Deformans; Radionuclide Imaging; Skull; Tomography, X-Ray Computed; Zoledronic Acid	2013
Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer research, 2002, Nov-15, Volume: 62, Issue:22 Topics: Angiogenesis Inhibitors; Animals; Bone and Bones; Cell Division; Cells, Cultured; Clodronic Acid; Diphosphonates; Endothelium, Vascular; Epithelial Cells; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Male; Neovascularization, Physiologic; Orchiectomy; Osteitis Deformans; Prostate; Rats; Rats, Sprague-Dawley; Risedronic Acid; Testosterone; Tissue Distribution; Zoledronic Acid	2002
Zoledronate treatment in active Paget's disease. Annals of the rheumatic diseases, 2003, Volume: 62, Issue:3 Topics: Alkaline Phosphatase; Bone Resorption; Diphosphonates; Humans; Imidazoles; Male; Middle Aged; Osteitis Deformans; Zoledronic Acid	2003
Pagetic hydrocephalus treated with zoledronate. Annals of the rheumatic diseases, 2005, Volume: 64, Issue:9 Topics: Aged; Aged, 80 and over; Diphosphonates; Female; Humans; Hydrocephalus; Imidazoles; Osteitis Deformans; Radiography; Skull; Zoledronic Acid	2005
Treatment of Paget's disease--taming the wild osteoclast. The New England journal of medicine, 2005, Sep-01, Volume: 353, Issue:9 Topics: Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Resorption; Diphosphonates; Glycoproteins; Humans; Imidazoles; Osteitis Deformans; Osteoclasts; Osteoprotegerin; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Zoledronic Acid	2005
Paget's disease and bisphosphonates. The New England journal of medicine, 2005, Dec-15, Volume: 353, Issue:24 Topics: Administration, Oral; Alendronate; Cost-Benefit Analysis; Diphosphonates; Drug Administration Schedule; Drug Costs; Etidronic Acid; Humans; Imidazoles; Osteitis Deformans; Risedronic Acid; Zoledronic Acid	2005
Paget's disease and bisphosphonates. The New England journal of medicine, 2005, Dec-15, Volume: 353, Issue:24 Topics: Administration, Oral; Alkaline Phosphatase; Diphosphonates; Disease Progression; Etidronic Acid; Humans; Imidazoles; Osteitis Deformans; Remission Induction; Risedronic Acid; Zoledronic Acid	2005
[Optimizing therapy in Paget disease]. MMW Fortschritte der Medizin, 2005, Dec-15, Volume: 147, Issue:51-52 Topics: Administration, Oral; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Follow-Up Studies; Humans; Imidazoles; Infusions, Intravenous; Osteitis Deformans; Randomized Controlled Trials as Topic; Risedronic Acid; Zoledronic Acid	2005
[Substance properties of zoledronate make it possible: bisphosphonate therapy only once yearly]. MMW Fortschritte der Medizin, 2006, Jun-22, Volume: 148, Issue:25 Topics: Aged; Aged, 80 and over; Alendronate; Biological Availability; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Etidronic Acid; Female; Geranyltranstransferase; Humans; Imidazoles; Male; Multicenter Studies as Topic; Osteitis Deformans; Osteoporosis, Postmenopausal; Patient Compliance; Placebos; Randomized Controlled Trials as Topic; Risedronic Acid; Surveys and Questionnaires; Time Factors; Zoledronic Acid	2006
[Zoledronic acid efficacy in Paget's disease of bone: a three-year experience]. Medicina clinica, 2006, Oct-28, Volume: 127, Issue:16 Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Osteitis Deformans; Zoledronic Acid	2006
Zoledronate: efficacy and safety. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2006, Volume: 21 Suppl 2 Topics: Aged; Diphosphonates; Humans; Imidazoles; Osteitis Deformans; Quality of Life; Zoledronic Acid	2006
Paget disease manifesting with compressive sixth-nerve palsy that resolved with intravenous zoledronic acid therapy. Archives of ophthalmology (Chicago, Ill. : 1960), 2007, Volume: 125, Issue:10 Topics: Abducens Nerve Diseases; Aged; Bone Density Conservation Agents; Diphosphonates; Diplopia; Humans; Imidazoles; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Nerve Compression Syndromes; Osteitis Deformans; Tomography, X-Ray Computed; Zoledronic Acid	2007
Paget disease of the spine manifested by thoracic and lumbar epidural lipomatosis: magnetic resonance imaging findings. Spine, 2007, Dec-01, Volume: 32, Issue:25 Topics: Bone Density Conservation Agents; Decompression, Surgical; Diphosphonates; Disease Progression; Epidural Space; Humans; Imidazoles; Laminectomy; Lipomatosis; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Osteitis Deformans; Paraparesis; Recurrence; Spinal Diseases; Spinal Stenosis; Thoracic Vertebrae; Treatment Outcome; Zoledronic Acid	2007
Paget's disease and bisphosphonate-associated osteonecrosis of the jaws. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2008, Volume: 66, Issue:6 Topics: Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Injections, Intravenous; Male; Maxillary Diseases; Osteitis Deformans; Osteonecrosis; Pamidronate; Zoledronic Acid	2008
Management of patients with Paget's disease: a consensus document of the Belgian Bone Club. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2008, Volume: 19, Issue:8 Topics: Bone Density Conservation Agents; Diagnosis, Differential; Diphosphonates; Drug Administration Schedule; Humans; Imidazoles; Osteitis Deformans; Treatment Outcome; Zoledronic Acid	2008
Zoledronate. British journal of clinical practice. Supplement, 1996, Volume: 87 Topics: Bone Neoplasms; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Multiple Myeloma; Osteitis Deformans; Osteoporosis; Zoledronic Acid	1996
Zoledronate in the treatment of Paget's disease. British journal of clinical practice. Supplement, 1996, Volume: 87 Topics: Aged; Alkaline Phosphatase; Amino Acids; Bone and Bones; Clinical Trials as Topic; Creatine; Diphosphonates; Drug Administration Schedule; Female; Humans; Hydroxyproline; Imidazoles; Male; Osteitis Deformans; Zoledronic Acid	1996